Cannabix Technologies, Inc. (OTC Pink: BLOZF) is engaged in developing a cannabis breathalyzer for law enforcement and employment applications. Shares of the cannabis breathalyzer company are diving 21%, during afternoon trading on Thursday, October 20, 2016. Over the past three months, Cannabix Technologies, Inc. has seen average daily volume of 224,255 shares. However, nearly 1.05 million shares or dollar volume of $420,000, has already exchanged hands through afternoon trading on Thursday.

Shares of Cannabix Technologies, Inc. are diving Thursday, after management announced they are working on a “2.0” cannabis breathalyzer. The major advances from the first model include: design and size changes, performance improvements, and greater sensitivity. Management says they are confident the new breathalyzer will allow for greater detection of smaller, trace amounts of THC, the active ingredient in marijuana. Management is developing a new model breathalyzer as nine more states have marijuana-related propositions on the ballot this November. Here is the press release detailing of the new model breathalyzer:

Cannabix Technologies, Inc. Press Release:

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Oct 19, 2016) – Cannabix Technologies Inc. (CSE:BLO)(BLO.CN)(OTC PINK:BLOZF) (the “Company”) provides an update on the development of its FAIMS (high-field asymmetric waveform ion mobility spectrometry) based instrument for detection of trace amounts of tetrahydrocannabinol (“THC”) from exhaled breath at the roadside and in the workplace. The Company is pleased to report that it has developed a “Beta 2.0” (Cannabix Marijuana Breathalyzer) device with major advances in the design and size of the device, including: greater sensitivity, improved performance by the square waveform generator. The current design includes features to allow for the addition of a rechargeable battery and touch screen and the device is approximately 10 times smaller than the Beta 1.0 device announced in July. Preliminary lab tests of the FAIMS device coupled with quadrupole ion trap mass spectrometry have shown lower levels of detection for THC standards than were achieved in past testing.

Scientific Testing for the FAIMS Cannabix Marijuana Breathalyzer

Cannabix scientists are formulating a scientific protocol to conduct live THC breath testing using the Beta 2.0 Cannabix Marijuana Breathalyzer in the coming weeks. The scientific testing will likely be conducted in Vancouver BC, Canada, where medical marijuana users will be engaged to determine the accuracy of the Beta 2.0 Cannabix Marijuana Breathalyzer to detect both smoked and edible consumption of marijuana in human breath. The results of the scientific tests will be used to prepare submissions for approval of the Cannabix Marijuana Breathalyzer as a court-approved device by the Minister of Justice in Canada and the National Highway and Safety Authority in the United States.

Kal Malhi, President of Cannabix stated, “Several states in the U.S. are voting to legalize recreational marijuana on November 8, 2016 and the need for law enforcement to have a tool to gather scientific evidence of marijuana impairment in drivers is becoming an urgent need. Cannabix Technologies has been diligently working on our Cannabix Marijuana Breathalyzer for approximately two years and we are excited to be at the advanced stage and preparing a device for law enforcement and employers to begin testing. We are making excellent progress with the objective of having an accurate and court accepted tool in the coming months.”

About Cannabix Technologies Inc.

Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace. Cannabix has established breath testing technologies in the pursuit of bringing durable, portable hand-held tools to market to enhance detection of marijuana impaired driving offences on roads at a time when marijuana is becoming legal in many global jurisdictions. Cannabix is working to develop drug-testing devices that will detect THC- the psychoactive component of marijuana that causes intoxication- using breath samples. In particular, Cannabix is focused on developing breath testing devices for detection of recent use of THC, in contrast to urine testing for THC metabolite that requires an invasive collection and reflects use days or even weeks earlier. The devices will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.

Add a Comment to this Post

comments